Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06718907 · ClinicalTrials.gov registry record · NA
Mitigating Response to Stressors in Pregnant Women
A NA study of Pregnancy, sponsored by Nova Southeastern University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06718907: Recruiting NA study of Pregnancy, sponsored by Nova Southeastern University.
NCT06718907 is a NA study of Pregnancy that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 50 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06718907, a NA study of Pregnancy, is actively recruiting participants, sponsored by Nova Southeastern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Stress-induced pregnancy complications are significant contributors to preterm labor as well as maternal and perinatal morbidity and mortality. The goals of this study are two folds: first it aims to capture the pregnant woman's journey to seek and receive prenatal care. Second, this study aims to develop models that 1) assess the adverse health and biological effects of social factors on pregnant women who experience repeated or chronic stress, 2) address how stress can be mitigated in pregnant women from different backgrounds who experience high stress.
Primary Outcome
change in stress measures as assessed by salivary cortisol levels from collected saliva before and after practicing stress management techniques. Cortisol levels are measured in ug/dL.
Conditions Studied
Interventions
- BEHAVIORAL Stress Management
- BEHAVIORAL Simulated stimuli
Study Locations (1)
Florida
- Nova Southeastern University - Davie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-12-20 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06718907 shows while recruiting
NCT06718907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Stress Management is the first listed.
NCT06718907 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06718907 about?
NCT06718907 is a clinical study titled "Mitigating Response to Stressors in Pregnant Women". Stress-induced pregnancy complications are significant contributors to preterm labor as well as maternal and perinatal morbidity and mortality. The goals of this study are two folds: first it aims to capture the pregnant woman's journey to seek and receive prenatal care. Second, this study aims to d...
What is the current status of trial NCT06718907?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-12-20. Estimated completion is 2026-12-31.
What conditions does trial NCT06718907 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT06718907?
The interventions under investigation include: Stress Management (BEHAVIORAL), Simulated stimuli (BEHAVIORAL).
Who is sponsoring clinical trial NCT06718907?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06718907 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06718907's enrollment target sits among peer trials
50 152nd of 191 higher than 34 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI